Illumina in den Nachrichten
Technologielösungen für die Genanalyse
Tamtam hat 20 aktuelle Artikel über Illumina gefunden.
- Illumina (NASDAQ: ILMN) CLO grants may pay up to 250% of target shares
- Advancing whole-genome sequencing with long-range data
- Evaluating new approaches for rare disease research
- Illumina (ILMN) Following Novacyt Deal Has Investors Asking If The Stock Looks Fully Valued
- Illumina Inc. stock underperforms Wednesday when compared to competitors
- This Illumina Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
- Illumina Insider Sells $57M in Stock as ILMN Prepares to Join S&P 500
- Palani Kumaresan: Roche Diagnostics Is Ramping Up—Should Illumina Be Worried?
- Illumina: Priced For Perfection It Hasn't Earned Yet (NASDAQ:ILMN)
- Bloom Energy, Everpure, Illumina to Join S&P 500 in September Rebalance
- A Look at Illumina Inc (ILMN) After 3.3% Decline -- GF Value $132.76 vs Price $211.06
- ILMN Stock Keeps Climbing. Should You Climb On?
- Partnership Deal And Rating Upgrade Altering The Investment Case For Illumina (ILMN)?
- Illumina and Everpure to Join S&P 500 in September Rebalancing: What it Means for Investors
- Illumina, a "pick company" of deoxyribonucleic acid (DNA) research, succeeded in re-establishing it
- How Illumina’s (ILMN) Novacyt Collaboration Framework Could Shape Its Clinical Sequencing Strategy
- The Trade Desk to leave S&P 500 as Bloom Energy, Everpure, Illumina join index
- Bloom Energy, Illumina and Everpure set to join S&P 500 before Sept. 21 open
- Illumina (ILMN) Stock Looks Priced For Growth More Than Value
- Bloom Energy, Illumina, and Everpure Are Joining the S&P 500. These 3 Stocks Are Leaving.
Von Tamtam gesammelte Artikel, die sich auf das Unternehmen beziehen, die neuesten zuerst. Jeder verlinkt auf seine Quelle.
Sie verkaufen an Unternehmen wie Illumina?
Tamtam findet die Unternehmen, die zu Ihrem idealen Kunden passen, recherchiert jeden Account und sagt Ihnen, wen Sie wann kontaktieren sollten.
Ähnliche Unternehmen finden